PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Hospital uses 'lean' manufacturing techniques to speed stroke care

American Heart Association Rapid Access Journal report

2012-10-19
(Press-News.org) A hospital stroke team used auto industry "lean" manufacturing principles to accelerate treatment times, according to new research in the American Heart Association's journal Stroke. In a prospective observational study, the average time between patients arriving at Barnes-Jewish Hospital in St. Louis, Mo., and receiving the clot-busting agent tissue plasminogen activator (tPA), decreased 21 minutes using process improvement techniques adapted from auto manufacturing. Data from more than 200 patients was included in the study analysis, ranging over 3 years. The shorter the time between patients arriving at the hospital and receiving tPA, the greater the chance to reduce brain injury after stroke, researchers said. Using lean techniques, the hospital's stroke team identified unnecessary or inefficient steps such as inefficient patient transportation, tasks performed one at a time rather than simultaneously, and time-consuming traditional lab-based tests. Protocols were formulated to eliminate wasteful steps, keeping only crucial steps that added "value" to patient care, in keeping with auto-manufacturers' lean methods which eliminates inefficiencies in automobile production. The team streamlined the process by having EMS route patients directly to the CT scanner for immediate brain imaging, enlisted the help of more team members each with fewer tasks to complete, and instituted bedside tests which provide laboratory results within minutes. These modifications ensured that rapid diagnosis and treatment would be available for patients as soon as they arrived at the Emergency Department. As a result, 78 percent of stroke patients received tPA within one hour of arrival. The "Get with the Guidelines" national database indicates that currently only about 30 percent of patients in the United States are treated within one hour. The overall treatment time was reduced from 60 minutes to 39 minutes — sustained for a year after implementation. The protocol changes didn't alter patient safety or clinical outcomes, researchers said. "There is growing awareness that fast and efficient treatment is important for improving the effectiveness of tPA. National guidelines suggest that door-to-needles times should be under 60 minutes, yet these guidelines do not state how this can be achieved. Lean process improvements methodology can be effectively applied towards achieving this and other process improvement goals," said Jin-Moo Lee, M.D., Ph.D., lead author of the study and Director of the Cerebrovascular Disease Section in the Department of Neurology at Washington University School of Medicine in St. Louis. A larger study is needed to validate results, researchers said. ### Other co-authors are Andria L. Ford, M.D.; Peter Panagos, M.D.; Jennifer A. Williams, R.N.; Mary Spencer, R.N., M.S.N.; Craig McCammon, Pharm.D.; Naim Khoury, M.D.; and Tomoko Sampson, M.D. Author disclosures are on the manuscript. NIH Specialized Programs of Translational Research in Acute Stroke (SPOTRIAS) and the Institute of Clinical and Translational Sciences at Washington University-St. Louis funded the study. Follow @HeartNews on Twitter for the latest heart and stroke news. For stroke science, follow the Stroke journal at @StrokeAHA_ASA.

Statements and conclusions of study authors published in American Heart Association scientific journals are solely those of the study authors and do not necessarily reflect the association's policy or position. The association makes no representation or guarantee as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations are available at www.heart.org/corporatefunding.


ELSE PRESS RELEASES FROM THIS DATE:

Child's home address helps predict risk of readmission to hospital

2012-10-19
Simply knowing a child's home address and some socioeconomic data can serve as a vital sign – helping hospitals predict which children admitted for asthma treatment are at greater risk for re-hospitalization or additional emergency room visits, according to new research in the American Journal of Public Health. The use of a so-called "geographic social risk index," based on census measures of poverty, home values and number of adults with high school degrees, also can help hospitals identify families likely to report financial or psychological hardship – both of which ...

Tropical collapse caused by lethal heat

2012-10-19
Scientists have discovered why the 'broken world' following the worst extinction of all time lasted so long – it was simply too hot to survive. The end-Permian mass extinction, which occurred around 250 million years ago in the pre-dinosaur era, wiped out nearly all the world's species. Typically, a mass extinction is followed by a 'dead zone' during which new species are not seen for tens of thousands of years. In this case, the dead zone, during the Early Triassic period which followed, lasted for a perplexingly long period: five million years. A study jointly led ...

Low calcium diet linked to higher risk of hormone condition in women

2012-10-19
Primary hyperparathyroidism or PHPT is caused by overactive parathyroid glands secreting too much parathyroid hormone, which can result in weak bones, fractures and kidney stones. In recent years, several studies have also suggested a link between untreated PHPT and an increased risk of high blood pressure, heart attack and stroke. PHPT affects one in 800 people during their lifetime. It is most common in post-menopausal women between 50-60 years of age. Calcium intake is known to influence parathyroid hormone production and therefore may be important in the development ...

Blood hormone levels can predict long-term breast cancer risk

2012-10-19
BOSTON, MA—Blood hormone tests can predict a woman's risk for developing postmenopausal breast cancer for up to 20 years, according to a study led by Xuehong Zhang, MD, Channing Division of Network Medicine, Brigham and Women's Hospital (BWH) Department of Medicine. The findings will be presented at the 11th Annual American Association for Cancer Research (AACR) International Conference on Frontiers in Cancer Prevention Research. Using data from the Nurses' Health Study, Zhang , Susan Hankinson, ScD, Channing Division of Network Medicine, BWH Department of Medicine ...

Living in ethnically homogenous area boosts health of minority seniors

2012-10-19
An African-American or Mexican-American senior living in a community where many neighbors share their background is less likely to have cancer or heart disease than their counterpart in a more mixed neighborhood. Results of the new study by Kimberly Alvarez, a PhD student at Columbia University's Mailman School of Public Health, and Becca Levy, PhD, associate professor of Epidemiology and Psychology at the Yale School of Public Health, appear in the December issue of the American Journal of Public Health and online. Counter to prevailing notions, researchers found ...

Stroke patients benefit from carmaker's efficiency

Stroke patients benefit from carmakers efficiency
2012-10-19
A process developed to increase efficiency and productivity in Japanese car factories has helped improve stroke treatment at Barnes-Jewish Hospital, report researchers at Washington University School of Medicine in St. Louis. By applying the principles of Toyota's lean manufacturing process, doctors sharply reduced the average time between patient arrival and treatment, known as door-to-needle time, from 58 to 37 minutes. The findings are reported Oct. 18 in the journal Stroke. In an average year, the medical school's physicians treat 1,300 stroke patients at Barnes-Jewish. Beginning ...

No antibodies, no problem

2012-10-19
Researchers at the Johns Hopkins Bloomberg School of Public Health have determined a new mechanism by which the mosquitoes' immune system can respond with specificity to infections with various pathogens, including the parasite that causes malaria in humans, using one single gene. Unlike humans and other animals, insects do not make antibodies to target specific infections. According to the Johns Hopkins researchers, mosquitoes use a mechanism known as alternative splicing to arrange different combinations of binding domains, encoded by the same AgDscam gene, into protein ...

Study shows breastfeeding reduced risk for ER/PR-negative breast cancer

2012-10-19
October 18, 2012 -- Breast-feeding reduces the risk for estrogen receptor-negative and progesterone receptor-negative breast cancer, according to a study conducted at Columbia University's Mailman School of Public Health. Researchers examined the association between reproductive risk factors — such as the number of children a woman delivers, breast-feeding and oral contraceptive use – and found an increased risk for estrogen receptor- and progesterone receptor- (ER/PR) negative breast cancer in women who do not breast-feed. The results also indicated that having three ...

Study shows elevated risk of blood clots in women taking birth control containing drospirenone

2012-10-19
OAKLAND, Calif., Oct. 18— A U.S. Food and Drug Administration-funded study led by the Kaiser Permanente Northern California Division of Research found an increased risk of arterial thrombotic events (ATE) and venous thromboembolic events (VTE) — commonly referred to as blockage of arteries and blood clots, respectively — associated with drospirenone-containing birth control pills compared to four low-dose estrogen combined hormonal contraceptives. The study appears in the current online issue of Contraception. "We found that starting use of drospirenone-containing combined ...

Caltech modeling feat sheds light on protein channel's function

Caltech modeling feat sheds light on protein channels function
2012-10-19
PASADENA, Calif.—Chemists at the California Institute of Technology (Caltech) have managed, for the first time, to simulate the biological function of a channel called the Sec translocon, which allows specific proteins to pass through membranes. The feat required bridging timescales from the realm of nanoseconds all the way up to full minutes, exceeding the scope of earlier simulation efforts by more than six orders of magnitude. The result is a detailed molecular understanding of how the translocon works. Modeling behavior across very different timescales is a major ...

LAST 30 PRESS RELEASES:

Thirty-year mystery of dissonance in the “ringing” of black holes explained

Less intensive works best for agricultural soil

Arctic rivers project receives “national champion” designation from frontiers foundation

Computational biology paves the way for new ALS tests

Study offers new hope for babies born with opioid withdrawal syndrome

UT, Volkswagen Group of America celebrate research partnership

New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll

Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes

University of Cincinnati Cancer Center presents research at AACR 2025

Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025

AACR: Researchers share promising results from MD Anderson clinical trials

New research explains why our waistlines expand in middle age

Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker

Chips off the old block

Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia

Cutting the complexity from digital carpentry

Lung immune cell type “quietly” controls inflammation in COVID-19

Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity

State and sociodemographic trends in US cigarette smoking with future projections

Young adults drive historic decline in smoking

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Chimpanzee stem cells offer new insights into early embryonic development

This injected protein-like polymer helps tissues heal after a heart attack

FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology

In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity

Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects

A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions

AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate

Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative

Structure dictates effectiveness, safety in nanomedicine

[Press-News.org] Hospital uses 'lean' manufacturing techniques to speed stroke care
American Heart Association Rapid Access Journal report